<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02118519</url>
  </required_header>
  <id_info>
    <org_study_id>KneeUJCTC</org_study_id>
    <nct_id>NCT02118519</nct_id>
  </id_info>
  <brief_title>Mesenchymal Stem Cells in Knee Cartilage Injuries</brief_title>
  <official_title>Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Induction of autologous repair chondrogenesis to regenerate injured articular cartilage using
      bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing
      conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fourteen patients from both genders, age range 40-68, will be enrolled according to strict
      inclusion and exclusion criteria, divided into two equal groups based upon receiving
      autologous MSCs alone, or MSCs supported by platelet lysate through percutaneous injection.

      The patients are followed by clinical assessment, laboratory investigations as well as
      magnetic resonance imaging (MRI) of the injected knee.

      The investigators hypothesize that the two groups will give satisfactory clinical outcomes,
      but the investigators are looking forward to assessing the best product that will activate
      chondrogenesis and heal cartilaginous injury.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the articular cartilage healing in osteoarthritic patients through intra articular injection of Autologus Mesenchymal stem cell with/or without supported product.</measure>
    <time_frame>12 months</time_frame>
    <description>For every patient tests would be performed repeated at 6, and 12 months post-injection.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Articular Cartilage Disorder of Knee</condition>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>mesenchymal stem cells</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autologous Mesenchymal Stem Cells primed prior to intra articular injection into knees of patients with advanced articular cartilage injury</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mesenchymal cells&amp;platelet lysate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autologous Mesenchymal Stem Cells primed prior to intra articular injection with platelet lysate into knees of patients with advanced articular cartilage injury</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous Mesenchymal Stem Cells</intervention_name>
    <description>Comparison of clinical outcomes of patients injected by mesenchymal stem cells only with patients injected with mesenchymal stem cells supported by platelet lysate</description>
    <arm_group_label>mesenchymal stem cells</arm_group_label>
    <arm_group_label>mesenchymal cells&amp;platelet lysate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MRI must show moderate/severe articular injury

          -  Serum collagen II must be above the normal value.

          -  Lesion site: Femoral and Tibial condyles or patella

          -  Admission of steroid , NSAID, pain killers must be stopped before 1 month

        Exclusion Criteria:

          -  Lesion size

          -  PT and PTT not within normal value

          -  Complete blood count ( Hb, PCV, and RBC) not within the normal value

          -  HIV and Hepatitis Antigens (B and C) detection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdallah Awidi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cell Therapy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahasen S Najjar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jordan University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiba Khalil, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Neelain University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cell Therapy Center, Jordan University Hospital</name>
      <address>
        <city>Amman</city>
        <zip>11942</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2014</study_first_submitted>
  <study_first_submitted_qc>April 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2014</study_first_posted>
  <last_update_submitted>February 23, 2016</last_update_submitted>
  <last_update_submitted_qc>February 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>Fatima Jamali</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Bone marrow derived Mesenchymal Stem Cells</keyword>
  <keyword>Knee articular cartilage injury</keyword>
  <keyword>Chondrogenesis</keyword>
  <keyword>orthopedics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

